Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Vertical Research Downgrades C.H. Robinson Worldwide to Sell

Vertical Research Downgrades C.H. Robinson Worldwide to Sell

Vertical Research analyst Jeffrey Kauffman downgrades C.H. Robinson Worldwide (NASDAQ:CHRW) from Hold to Sell.

byBenzinga Newsdesk

August 17, 2022

1 minute read

Vertical Research analyst Jeffrey Kauffman downgrades C.H. Robinson Worldwide (NASDAQ:CHRW) from Hold to Sell.

Raymond James Maintains Strong Buy on National Retail Props, Lowers Price Target to $48

By Benzinga Newsdesk

October 4, 8:17 AM

Raymond James analyst RJ Milligan maintains National Retail Props (NYSE:NNN) with a Strong Buy and lowers the price target from $52 to $48.

NNN

Raoul Pal Says This Crypto Is Getting ‘Very Interesting’ As It Soars 85% Against Ethereum This Year

By Mehab Qureshi

February 21, 10:00 AM

Raoul Pal, a former Goldman Sachs executive and a macroeconomic guru, said Solana's chart is getting "very interesting" - with its value already up 85% this year.

ETH

News

Shuttle Pharmaceuticals Awarded New HDAC Inhibitor Patents For Cancer Treatment

By Benzinga Newsdesk

September 15, 8:43 AM

Company awarded patents in the U.S. and Hong Kong

SHPH

U.S. Stocks Settle Flat But Market Volatility Increases Slightly

By Lisa Levin

August 9, 4:14 AM

U.S. stocks settled mostly flat on Monday, with the dollar seeing a decline as investors assessed the recent economic reports.

NVDA

Vertical Research Downgrades C.H. Robinson Worldwide to Sell

Related Posts

Raymond James Maintains Strong Buy on National Retail Props, Lowers Price Target to $48

Raoul Pal Says This Crypto Is Getting ‘Very Interesting’ As It Soars 85% Against Ethereum This Year

Shuttle Pharmaceuticals Awarded New HDAC Inhibitor Patents For Cancer Treatment

U.S. Stocks Settle Flat But Market Volatility Increases Slightly